Shanghai Universal Biotech Co.,Ltd.

301166

CNE100005709

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-28 pm EDT			5-day change	1st Jan Change
29.7 ^CNY	+2.13%		+7.41%	-22.70%

Apr. 26	Shanghai Universal Biotech Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 22	Shanghai Universal Biotech Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Shanghai Universal Biotech Co.,Ltd. authorizes a Buyback Plan.

February 28, 2024

The Board of Directors of Shanghai Universal Biotech Co.,Ltd. has authorized a buyback plan on February 29, 2024.

Latest news about Shanghai Universal Biotech Co.,Ltd.

Shanghai Universal Biotech Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 26	CI
Shanghai Universal Biotech Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 22	CI
Tranche Update on Shanghai Universal Biotech Co.,Ltd.'s Equity Buyback Plan announced on March 2, 2024.	Apr. 01	CI
Shanghai Universal Biotech Co.,Ltd. announces an Equity Buyback for CNY 50 million worth of its shares.	Mar. 01	CI
Shanghai Universal Biotech Co.,Ltd. authorizes a Buyback Plan.	Feb. 28	CI
Sengenics Corporation LLC Enters into Sales Distribution and Services Agreement with Shanghai Universal Biotech Co., Ltd	Feb. 26	CI
Shanghai Universal Biotech Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-27	CI
Shanghai Universal Biotech Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-28	CI
Shanghai Universal Biotech Co.,Ltd. Announces Final Dividend for 2022, Payable on 29 May 2023	23-05-22	CI
Shanghai Universal Biotech Approves Final Cash Dividend for 2022	23-05-19	CI
Shanghai Universal Biotech Co.,Ltd. Proposes Final Cash Dividend for the Year 2022	23-04-27	CI
Shanghai Universal Biotech Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-26	CI
Shanghai Universal Biotech Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-26	CI
Shanghai Universal Biotech Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-26	CI
Shanghai Universal Biotech Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-29	CI
Shanghai Universal Biotech Co.,Ltd. Implements Final Cash Distribution for the Year of 2021, Payable on June 1, 2022	22-05-25	CI
Shanghai Universal Biotech Co.,Ltd. Approves Cash Dividend for the Year 2021	22-05-19	CI
Shanghai Universal Biotech Co.,Ltd. Proposes Final Dividend for 2021	22-04-25	CI
Shanghai Universal Biotech Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-25	CI
Shanghai Universal Biotech Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-24	CI
Absin Bioscience Inc. announced that it expects to receive CNY 71 million in funding from Shanghai Universal Biotech Co.,Ltd.	22-02-19	CI
Shanghai LabEx Biotechnology Co., Ltd. announced that it expects to receive CNY 15 million in funding from Shanghai Universal Biotech Co.,Ltd.	22-02-19	CI

Chart Shanghai Universal Biotech Co.,Ltd.

Duration

Period

Chart Shanghai Universal Biotech Co.,Ltd.

More charts

Shanghai Universal Biotech Co Ltd is a China-based company mainly engaged in the supply of life science reagent products. The Company is also engaged in the supply of life science instruments and consumables and comprehensive technical services. The products supplied by the Company are mainly third-party brand products, supplemented by independent brand products. The life science reagents mainly include immunological reagents based on antibodies and antibody related reagents, as well as molecular biology reagents, cell biology reagents and biochemical reagents. The life science instruments and consumables include detection and analysis and sample preparation. The comprehensive technical services include experimental services, technical support services and other services.

Sector

Pharmaceuticals

Calendar

2024-05-16 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Sector Pharmaceuticals Wholesale

	1st Jan change	Capi.
SHANGHAI UNIVERSAL BIOTECH CO.,LTD.	-22.70%	348M
MCKESSON CORPORATION	+15.79%	71.39B
CARDINAL HEALTH, INC.	+2.09%	25.1B
SINOPHARM GROUP CO. LTD.	-1.22%	8.59B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+7.95%	8.19B
HUADONG MEDICINE CO., LTD	-20.48%	7.91B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	+15.26%	4.31B
EBOS GROUP LIMITED	-1.24%	3.93B
GALENICA AG	-3.02%	3.86B
CHINA NATIONAL MEDICINES CORPORATION LTD.	+21.10%	3.64B